PROM1 and brain neoplasm: Immunohistochemistry study on formalin-fixed and paraffin-embedded (FFPE) mouse brain tumor tissue demonstrated that cell surface CSC marker CD133 and oncogene c-Myc expressions were both significantly decreased in enzalutamide-treated mice tumors compared with those in control group (Figures 6E, F).